COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY

Mark C. Gillies; Alex P. Hunyor; Jennifer J. Arnold; Francois Pecheur; Kathryn Underhill; Robyn H. Guymer; Ian L. McAllister

COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY

Mark C. Gillies, Alex P. Hunyor, Jennifer J. Arnold, Francois Pecheur, Kathryn Underhill, Robyn H. Guymer, Ian L. McAllister

Centre for Ophthalmology and Visual Science (affiliated with the Lions Eye Institute)

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	29-29
Number of pages	1
Journal	Clinical & Experimental Ophthalmology
Volume	45
Publication status	Published - Oct 2017

Cite this

Gillies, M. C., Hunyor, A. P., Arnold, J. J., Pecheur, F., Underhill, K., Guymer, R. H., & McAllister, I. L. (2017). COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY. Clinical & Experimental Ophthalmology, 45, 29-29.

Gillies, Mark C. ; Hunyor, Alex P. ; Arnold, Jennifer J. et al. / COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL : EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY. In: Clinical & Experimental Ophthalmology. 2017 ; Vol. 45. pp. 29-29.

@article{a34d0cb441934f65bf6ceff3600440c4,

title = "COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY",

author = "Gillies, {Mark C.} and Hunyor, {Alex P.} and Arnold, {Jennifer J.} and Francois Pecheur and Kathryn Underhill and Guymer, {Robyn H.} and McAllister, {Ian L.}",

year = "2017",

month = oct,

language = "English",

volume = "45",

pages = "29--29",

journal = "Clinical & Experimental Ophthalmology",

issn = "1442-6404",

publisher = "John Wiley & Sons",

}

Gillies, MC, Hunyor, AP, Arnold, JJ, Pecheur, F, Underhill, K, Guymer, RH & McAllister, IL 2017, 'COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY', Clinical & Experimental Ophthalmology, vol. 45, pp. 29-29.

COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY. / Gillies, Mark C.; Hunyor, Alex P.; Arnold, Jennifer J. et al.
In: Clinical & Experimental Ophthalmology, Vol. 45, 10.2017, p. 29-29.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL

T2 - EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY

AU - Gillies, Mark C.

AU - Hunyor, Alex P.

AU - Arnold, Jennifer J.

AU - Pecheur, Francois

AU - Underhill, Kathryn

AU - Guymer, Robyn H.

AU - McAllister, Ian L.

PY - 2017/10

Y1 - 2017/10

M3 - Abstract/Meeting Abstract

SN - 1442-6404

VL - 45

SP - 29

EP - 29

JO - Clinical & Experimental Ophthalmology

JF - Clinical & Experimental Ophthalmology

ER -

Gillies MC, Hunyor AP, Arnold JJ, Pecheur F, Underhill K, Guymer RH et al. COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A 'TREAT AND EXTEND' PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12-MONTH INTERIM ANALYSIS OF THE RIVAL STUDY. Clinical & Experimental Ophthalmology. 2017 Oct;45:29-29.